The hottest Biotechnology Substack posts right now

And their main takeaways
Category
Top Science Topics
Faster, Please! 182 implied HN points 28 Nov 25
  1. AI technology can greatly impact our lives and the way we think about democracy. We need to consider how it may change human behavior and society.
  2. Biotechnology has potential risks that could affect human nature itself. It's important to reflect on how these advancements might alter what it means to be human.
  3. Discussions about technology should include both excitement about progress and caution about the challenges. Balancing innovation with ethical considerations is key.
FreakTakes 15 implied HN points 19 Feb 26
  1. Proteins can be engineered to act as “universal fabricators” that assemble materials with molecular precision, opening the door to new classes of electronic, energy, and structural materials beyond today’s manufacturing methods.
  2. Small, interdisciplinary Frontier Research Contractor (BBN/FRC) teams—combining protein engineers, soft-matter experts, mineralization specialists, and process engineers—are the right organizational form to iterate quickly from sequence to macroscopic, functional assemblies.
  3. Building this vision requires infrastructure partners that scale protein production and rapid metrology, and those supplier FRCs can be commercially viable by serving multiple industries while accelerating the core materials programs.
Common Sense with Bari Weiss 505 implied HN points 11 Aug 25
  1. He Jiankui claims to be a pioneer of gene editing, but his past actions have earned him a bad reputation. He created the first gene-edited babies, which was condemned by many as unethical.
  2. The CRISPR-Cas9 gene editing tool was developed by Jennifer Doudna and Emmanuelle Charpentier, but He used it in a controversial way without their collaboration.
  3. Now out of prison, He plans to open a lab in Austin, Texas, where he wants to research Alzheimer’s in hopes of applying gene editing in the future.
A Biologist's Guide to Life 22 implied HN points 12 Feb 26
  1. Biotechnology—from ancient agriculture to modern medicine—powers food and health and has transformed human society and life expectancy.
  2. Research tools like sequencing, PCR, CRISPR, and lab automation accelerate discovery and are often easier to commercialize than whole crops or drugs because they avoid heavy clinical and scaling barriers; selling them means convincing scientists they cut costs or enable new, publishable work.
  3. Building biotech companies is very different from building software: it requires lab space, expensive reagents, patents, regulatory know-how, and often partnerships with big ag or pharma, so science training should better prepare people for these practical business and legal realities.
Niko McCarty 159 implied HN points 27 May 24
  1. Scientists can now deliver single molecules into living cells using special tools called nanopipettes. This could help in studying cell functions more precisely.
  2. Neuralink is facing problems with its brain chip as most of the threads inserted in the first human are not working. They plan to implant another chip in another person soon.
  3. Greenpeace is blocking the planting of Golden Rice, which is modified to help prevent vitamin A deficiency. This decision may change as the Philippine government intends to challenge it.
Get a weekly roundup of the best Substack posts, by hacker news affinity:
A Biologist's Guide to Life 29 implied HN points 26 Jan 26
  1. Living systems are layers of metabolic machines — from genes and proteins to cells, tissues, and organisms — that act like modular, self-replicating components we can study and engineer.
  2. Physical automation (robotic labs, cloud labs) and digital automation (AI-driven biodesign and structure prediction) can make experiments much cheaper, higher-throughput, and faster, enabling far more data and quicker innovation.
  3. Widespread automation is limited by trust, data security, and the need for flexibility as methods evolve, so modular, autonomous lab systems and careful governance are needed to realize its promise.
Common Sense with Bari Weiss 324 implied HN points 11 Aug 25
  1. Gene-editing technology has incredible potential to eliminate serious genetic diseases, which could save many lives. It's a powerful tool that could help create healthier babies.
  2. Some worry that this technology might lead to unethical choices, like selecting traits for intelligence or looks instead of just focusing on health. This could create a new form of eugenics.
  3. There's a big debate happening on whether designing babies is ethical or necessary. It's important for society to carefully consider the implications of these advancements for our future.
The Works in Progress Newsletter 45 implied HN points 08 Jan 26
  1. Vaccines used to be lucky accidents but are now deliberately designed using detailed knowledge of microbes, cells, and the immune system.
  2. New tools let us build precise vaccines from specific proteins or mRNA, making them safer, easier to optimize, and avoid using whole pathogens.
  3. Faster sequencing, better delivery systems, and improved manufacturing let vaccines be developed and updated in weeks, and continued investment will unlock even more progress.
Niko McCarty 119 implied HN points 30 May 24
  1. A company has set a new record by placing over 4,000 electrodes on a living human brain. This is a big step in brain-computer interface technology.
  2. There are some significant papers about CRISPR technology that are worth checking out. These studies could impact how we use gene editing in the future.
  3. A certain microbe can significantly reduce harmful gas emissions in soil. This is important because it's a natural solution that doesn't involve genetic engineering.
Asimov Press 335 implied HN points 28 Jul 25
  1. Gene therapies are designed to fix problems caused by genetic mutations, and there are many delivery methods available to target these issues. The choice of delivery method depends on how the gene needs to be delivered and what condition is being treated.
  2. Two common types of gene therapies are _ex vivo_ (where cells are modified outside the body and then put back) and _in vivo_ (where the therapy is delivered directly into the body). Each has its own advantages based on the target cells and diseases.
  3. When choosing a gene delivery vehicle, factors like how much genetic material can be delivered, the ability to target specific cells, and immune responses need to be carefully considered to ensure effective and safe therapy.
Trevor Klee’s Newsletter 970 implied HN points 07 Jan 25
  1. Genentech is seen as the start of the biotech field because it combined new technology with business and research. This company pioneered how biotech operates today.
  2. Regulations nearly stopped Genentech from forming, creating fears about safety and ethics in biotechnology. However, Genentech managed to navigate around these regulations and succeed.
  3. Unlike big companies, Genentech used private funding and worked in less regulated spaces. This allowed them to develop human insulin without the heavy regulatory burden faced by larger firms.
Bzogramming 45 implied HN points 31 Dec 25
  1. Most practical technology is built from atoms, electrons, and photons, so discovering new high-energy particles isn’t what drives usable engineering; progress comes from better math, materials, and system design.
  2. Condensed-matter and materials science (like semiconductors and superconductors) are where real, applicable breakthroughs live, because emergent behaviors of many atoms produce useful properties we can actually engineer.
  3. The next big advances will come from new algorithms, mathematical tools, and using physical and biological systems as computational substrates (aided by ML), not from finding exotic particles; building bigger, smarter systems from known primitives is the path forward.
ASeq Newsletter 21 implied HN points 29 Jan 26
  1. Several companies now offer compact, high‑throughput nanopore sequencers (Qitan Q‑P2, MGI CycloneSeq/G100‑ER, PolySeq X2, Meilitech), but most models are currently sold mainly in China or Russia and are hard to obtain elsewhere.
  2. MGI's CycloneSeq is the most likely near‑term global alternative, yet it faces legal/IP disputes, possible sales restrictions and tariffs, unclear pricing, and reports of lower data quality compared with established platforms.
  3. The growing number of competitors shows nanopore know‑how isn't exclusive to one company, so competing platforms will probably improve and become more widely available over time.
De Novo 77 implied HN points 17 Nov 25
  1. Eggs are rare and expensive, which limits how many embryos we can select from for genetic improvement. Finding a way to effectively use sperm could change this.
  2. The proposed method involves making eggs, removing their DNA, and then adding sperm to create cell lines. This lets us select the best genetic traits without wasting sperm.
  3. This approach could improve the chances of getting better traits from the father side and could work even with low-quality techniques for making eggs.
Niko McCarty 99 implied HN points 25 May 24
  1. Chick culling is a big issue where billions of male chicks are killed each year because they can't lay eggs. New technology can help determine an egg's sex earlier to prevent this cruelty.
  2. Synthetic apomixis could change farming for the better by allowing farmers to grow hybrid crops indefinitely without buying new seeds each year. This would help increase their profits and food supply.
  3. Tree engineering is important for combating climate change, but not enough researchers are focusing on it. Creating trees that grow faster and capture more carbon could help protect our forests.
ASeq Newsletter 7 implied HN points 19 Feb 26
  1. The SpotFire stood out among sample-to-answer qPCR machines.
  2. It appears to use the same two-stage amplification process as the FilmArray.
  3. It shortens time to result from about 45 minutes to around 15 minutes.
ASeq Newsletter 7 implied HN points 18 Feb 26
  1. They developed a fluidic micropillar system that separates DNA using microfluidic flows.
  2. The tech is focused on preserving and recovering high‑molecular‑weight (long) DNA for long‑read nanopore sequencing.
  3. The aim is a fast, integrated microfluidic sample‑to‑library workflow to speed up nanopore sequencing preparation.
Viruses Must Die 44 implied HN points 19 Dec 25
  1. Ordinary brewer's yeast can be engineered into food-grade vaccines, and the experiments were reportedly doable on a simple household budget.
  2. This method could decentralize vaccine production so people or local microbreweries could make vaccines, potentially bypassing slow licensing and surviving even severe social disruptions.
  3. The target is viruses like polyomaviruses that cause serious illness (for example painful bladder disease in transplant patients), so edible vaccines could prevent a lot of suffering.
ASeq Newsletter 7 implied HN points 17 Feb 26
  1. The MGI FLP-L50 is a highly integrated sample-to-answer DNA sequencer that combines many steps into one device.
  2. It takes a different approach from other sample-to-answer sequencers previously discussed, offering a unique level of integration.
  3. The instrument reportedly has strong sales in China, suggesting commercial traction in that market.
Telescopic Turnip 31 implied HN points 28 Dec 25
  1. Some viruses can trigger bacteria to self-organize into a single, coordinated structure, producing collective behaviors that look a lot like a hive mind.
  2. Gene-level molecular clocks suggest mitochondria were acquired relatively late, after the nucleus, cytoskeleton, and vesicle-transport systems had already evolved, which challenges the idea that mitochondria jump-started eukaryotic complexity.
  3. Forbidding children from moving or fidgeting appears to impair creativity, and larger studies are needed before treating stillness as a universal schooling requirement.
Viruses Must Die 35 implied HN points 24 Dec 25
  1. Live brewer’s yeast engineered to make viral proteins can be put into beer and may trigger antibody responses; the authors drank such “vaccine beer” and reported no discernible side effects.
  2. They show you can recreate the necessary plasmids and brew vaccine-containing beer outside a university lab using commercial DNA synthesis and readily available home-lab and brewing supplies, making the approach accessible to homebrewers and small food producers.
  3. They argue food-based vaccines could lower cost and increase access, and that current US law could allow these products to be marketed as GRAS foods so long as no disease-prevention claims are made, while formal medical efficacy testing would remain under regulatory oversight.
Not Boring by Packy McCormick 205 implied HN points 18 Jul 25
  1. There are massive investments in AI infrastructure, mainly in Pennsylvania, with companies like Google and Blackstone pledging billions to build data centers. This investment is expected to create many jobs and boost the local economy.
  2. Meta is working on building a huge data center called Hyperion, which will provide lots of power for AI development. They plan to invest around $70 billion in AI this year, which could lead to significant advancements in their products.
  3. A new study shows that a technique called three-person IVF can produce healthy children by combining DNA from three people to prevent genetic diseases. This could change how families with these conditions approach reproduction.
Viruses Must Die 35 implied HN points 21 Dec 25
  1. Vaccines can be delivered through everyday foods like yeast or beer, which could make immunization simpler, cheaper, and more widely accessible.
  2. The current drug approval system’s heavy safety theater and monopoly incentives have increased public distrust and helped anti-vaccine sentiment gain influence.
  3. Treating vaccine-foods as consumer products with independent third-party testing and public reviews could rebuild trust, encourage competition, and provide transparent information on safety and effectiveness.
Asimov Press 490 implied HN points 19 Feb 25
  1. Evo 2 is a powerful AI model that can design entire genomes and predict harmful genetic mutations quickly. It can help scientists understand genetics better and improve genetic engineering.
  2. Unlike earlier models, Evo 2 can analyze large genetic sequences and understand their relationships, making it easier to see how genes interact in living organisms.
  3. While Evo 2 offers exciting possibilities for bioengineering, there are also concerns about its potential misuse. It's important to handle such powerful technology responsibly to avoid harmful applications.
Briefly Bio 198 implied HN points 23 Feb 24
  1. Creating 96-well plate maps is important for organizing samples and tracking metadata during scientific experiments. This helps scientists during pipetting and later data analysis.
  2. Current methods for making plate maps, like using spreadsheets, can be clunky and error-prone as they often require managing multiple tables that are not linked.
  3. A new visual plate mapper allows for easy creation and editing of plate maps. It synchronizes the visual layout with a data table, making it simpler to manage and analyze experiment data.
ASeq Newsletter 7 implied HN points 12 Feb 26
  1. Many commercial systems fully automate sample-to-answer molecular testing and produce results in roughly 13–120 minutes.
  2. The market spans traditional qPCR platforms and newer isothermal or novel technologies, offered by a wide range of companies.
  3. Sequencing still needs extensive prep and trained staff, so automated sample-to-answer molecular platforms are more practical for rapid diagnostics, and several novel approaches are worth watching.
Not Boring by Packy McCormick 189 implied HN points 04 Jul 25
  1. Hermeus is making waves in aviation by speeding up aircraft development, aiming to make travel faster and improve social and economic growth in America. They're pushing for supersonic travel to bring the excitement back to flying.
  2. The FAETON-I fusion device from Fuse Energy is a big step toward making fusion energy a reality, with some impressive outcomes that could change the future of energy production. This could lead to safer world and more available energy for everyone.
  3. Chai Discovery's new AI model, Chai-2, is revolutionizing how antibodies are designed, making the process faster and more efficient. This advancement could lead to better treatments for diseases much quicker than before.
LatchBio 54 implied HN points 13 Nov 25
  1. SpatialBench offers a set of 98 evaluation packs to measure how well spatial agents perform on real tasks, helping to compare different technologies effectively.
  2. The evaluations are designed from actual tasks scientists face, making them useful to assess real-world analysis abilities in biology.
  3. There's a need for specialized tools and resources in biology since standard coding methods don’t easily translate to biological analysis tasks.
Viruses Must Die 26 implied HN points 24 Dec 25
  1. Whether something is a food or a drug depends on how it’s marketed and labeled, not just the ingredient itself, so calling an item a "vaccine" by itself doesn’t automatically make it a drug. Food products can contain bioactive ingredients and still be regulated as foods if no disease-treatment claims are made.
  2. You can legally sell organisms that can produce vaccine antigens as foods (for example, yeast that only makes the antigen when brewed with maltose) to establish prior food marketing and preserve the option to later pursue clinical IND studies. This "vac foods" approach aims to democratize vaccine development while keeping production transparent to consumers.
  3. Safety and regulatory rules matter: GRAS status, IND timing, and ingredient safety (e.g., viral VP1, GFP, residual formaldehyde, yeast strains) are central concerns, and this strategy is legally novel and should be pursued with caution and clear disclosure.
The Generalist 500 implied HN points 19 Dec 24
  1. We need to improve government hiring processes to attract good talent. Many talented people are turned off by low pay and slow bureaucratic procedures.
  2. Public investment in scientific research can lead to breakthroughs that the private market often ignores. Funding areas like disease research or innovative technologies can yield unexpected benefits for society.
  3. Understanding and improving how government works is essential. There are many effective ways to enhance efficiency that are often overlooked but can significantly help society.
Not Boring by Packy McCormick 157 implied HN points 11 Jul 25
  1. A company called Rainmaker is trying to make it rain through technology. However, they face a lot of backlash from people who blame them for natural disasters like flooding, even when science shows they aren't responsible.
  2. Peter Jackson, the director of 'Lord of the Rings,' is investing $15 million to bring back the moa, a giant bird that went extinct 600 years ago. It's exciting to see famous figures support scientific projects, even if they seem a bit out there.
  3. A robot recently performed surgery on a model without human guidance, adapting in real time. This could change how surgeries are done in the future, making them safer and potentially less expensive.
ASeq Newsletter 21 implied HN points 30 Dec 25
  1. Roche unexpectedly brought a high‑throughput nanopore sequencer that looks competitive with Illumina on throughput, quality, and cost, implying single‑molecule sequencing could reshape the market.
  2. Oxford Nanopore faces leadership change and financial pressure after massive investment, and growing competition (including Chinese clones and Roche) threatens its hard‑won nanopore lead.
  3. Illumina remains the largest player but is showing flat revenue and shifting toward clinical markets, while PacBio—despite leading on long‑read quality—struggles with limited adoption and a small market.
More is Different 6 implied HN points 07 Feb 26
  1. Engineered baker's yeast that displays viral proteins can trigger protective antibody responses when eaten, showing edible vaccines are possible.
  2. Yeast vaccines can be produced and distributed quickly and locally—through brewing, dried chips, or feed—making decentralized pandemic and livestock responses feasible.
  3. Edible yeast vaccines may reduce needle-related hesitancy and lower some regulatory barriers, but they still face important challenges like oral tolerance, safety, and the need for proper clinical trials and regulatory clarity.
ASeq Newsletter 14 implied HN points 13 Jan 26
  1. Oxford Nanopore presented at the JPM conference following the release of preliminary results.
  2. Management reiterated their commitment to deliver break-even by 2027.
  3. They didn’t report full losses; cash reserves appear consistently down and cash reverses could mean reported losses are smaller than earlier expectations.
FreakTakes 7 implied HN points 30 Jan 26
  1. The team’s North Star is to make plant engineering like chip design — building synthetic chromosomes and easy, plug-and-play genetic parts so people can design complex, adaptive plant traits.
  2. Progress is blocked by three main technical bottlenecks: transforming and regenerating many plant species, a lack of validated higher-level genetic circuit libraries, and immature hardware to build and iterate large DNA programs.
  3. They fund tool development by mixing contracts and grants, using a high-throughput screening platform to offer screening and co-development services, and aim to grow into an engineering research institute that would need roughly $3–7M per year for about a decade.
De Novo 99 implied HN points 28 Jul 25
  1. Researchers are working on a new gene drive to help mosquitoes resist malaria. This approach could be a new way to fight the disease without reducing mosquito populations.
  2. The gene drive targets a specific gene in mosquitoes to prevent malaria parasites from spreading. This means fewer mosquitoes would carry the malaria parasite after feeding on infected blood.
  3. There are still questions to answer about this approach, like how effective it would be in different mosquito species and whether it could lead to new issues with mosquito populations.
TheSequence 133 implied HN points 29 Jun 25
  1. AlphaGenome is a new AI model that helps understand the genome better. It predicts various functions in DNA, enabling quick analysis of genetic variants.
  2. This model combines different types of data into one system, making it easier and faster to see how genetic changes might affect health.
  3. DeepMind is offering early access to AlphaGenome for researchers, encouraging collaboration between academia and industry to unlock more discoveries in genetics.
ASeq Newsletter 21 implied HN points 16 Dec 25
  1. Meilitech has introduced the MerrySeq nanopore platform with modest claimed performance (around 95% accuracy) and small device pore counts (1–96), positioning it differently from bigger competitors.
  2. The platform emphasizes reusability and openness: chips are advertised as reusable 5–10 times with dry/wet separation, and the system offers multiple pore protein options plus raw-trace output for user tinkering.
  3. The product looks less mature than other offerings but could be attractive as a low‑cost, hackable research tool; it also sells patch‑clamp rigs and standard data outputs, though real-world availability and performance are unclear.